Date | Compound | Laboratory | Indication | Type of Information |
---|---|---|---|---|
2014-07-16 | 2-[(6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thienol[3,2,-f]-[1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]-N-(4-hydroxyphenyl)-acetamide dihydrate | OncoEthix (Switzerland) | acute myeloid leukemia |
Granting of the orphan status in the US |
2014-07-21 | antibody drug conjugate consisting of fully human anti-guanylyl cyclase C monoclonal antibody linked to the cytotoxic drug monomethyl auristatin E | Millennium Pharmaceuticals (USA - MA) | gastric cancer |
Granting of the orphan status in the US |
2014-07-29 | calcifediol - vitamin D prohormone | OPKO Health (USA - FL) | secondary hyperparathyroidism (SHPT) in patients with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency |
Granting of a patent |
2014-07-29 | dexamethasone | Allergan (USA - CA) | diabetic macular edema |
Granting of a Market Authorisation in the EU |
2014-07-29 | recombinant protein carrying human papillomavirus (HPV) epitopes inserted in an adenylate cyclase protein | Genticel (France) | HPV infection |
Granting of a patent |
2014-07-29 | HPV infection treatment comprising proprietary methods | Genticel (France) | Granting of a patent | |
2014-07-29 | composition for eliciting a specific cytotoxic T cell response, comprising a lympho-ablative compound and a molecule (containing an antigenic sequence) that targets professional antigen-presenting cells. | Genticel (France) | cervical carcinoma, HPV-associated anal and oropharyngeal cancers |
Granting of a patent |
2014-08-26 | (3S)-1-azabicyclo[2.2.2]oct-3-yl{2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl}carbamate | Genzyme (USA - MA), a Sanofi company (France) | Fabry disease |
Granting of the orphan status in the US |
2014-07-30 | 17alpha,21-dihydroxy-16alpha-methyl-pregna-1,4,9(11)-triene-3,20-dione | NDA Group AB (Sweden) | Duchenne muscular dystrophy (DMD) |
Granting of the orphan status in the EU |
2014-07-30 | gevokizumab | Servier (France) | Schnitzler syndrome |
Granting of the orphan status in the EU |
2014-07-30 | recombinant factor VIIa modified with three terminal repeats derived from the Beta chain of human chorionic gonadotropin | Richardson Associates Regulatory Affairs (UK) | congenital factor VII deficiency |
Granting of the orphan status in the EU |
2014-07-30 | recombinant factor VIIa modified with three terminal repeats derived from the Beta chain of human chorionic gonadotropin | Richardson Associates Regulatory Affairs (UK) | haemophilia A |
Granting of the orphan status in the EU |
2014-07-30 | recombinant factor VIIa modified with three terminal repeats derived from the Beta chain of human chorionic gonadotropin | Richardson Associates Regulatory Affairs (UK) | haemophilia B |
Granting of the orphan status in the EU |
2014-07-30 | recombinant fusion protein consisting of a modified form of the extracellular domain of human activin receptor IIB linked to the human IgG1 Fc domain | IDEA Innovative Drug European Associates (UK) | myelodysplastic syndrome |
Granting of the orphan status in the EU |
2014-07-30 | recombinant human apolipoprotein A-I in a complex with phospholipids | Cerenis Therapeutics (France) | apolipoprotein A-I deficiency |
Granting of the orphan status in the EU |
2014-07-30 | recombinant human apolipoprotein A-I in a complex with phospholipids | Cerenis Therapeutics (France) | ATP- binding cassette transporter A1 deficiency |
Granting of the orphan status in the EU |
2014-07-30 | retinol | Dr Philipp Heinrich Novak (Austria) | prevention of bronchopulmonary dysplasia |
Granting of the orphan status in the EU |
2014-07-30 | sodium ascorbate and menadione sodium bisulfite | JJGConsultancy (UK) | autosomal dominant polycystic liver disease |
Granting of the orphan status in the EU |
2014-07-30 | 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethylsulfamide | DualTpharma (The Netherlands) | small cell lung cancer |
Granting of the orphan status in the EU |
2014-07-30 | ulinastatin | BSV BioScience (Germany), subsidiary of Bharat Serums &Vaccines (India) | ulinastatin |
Granting of the orphan status in the EU |
© 2024 Biopharmanalyses - Powered by Samacom+